Biomedical Engineering Reference
In-Depth Information
Scadden, D. 2006. The stem-cell niche as an entity of action. Nature 441: 1075-1079.
Scheel, C., Onder, T., Karnoub, A., and Weinberg, R. 2007. Adaptation versus selection: the
origins of metastatic behavior. Cancer Research 67: 11476-11479.
Schofield, R. 1978. The relationship between the spleen colony-forming cell and the haemo-
poietic stem cell. Blood Cells 4: 7-25.
Shackelton, M., Vaillant, F., Simpson, K., Stingl, J., Smyth, G., et al. 2006. Generation of a
functional mammary gland from a single stem cell. Nature 439: 84-88.
Sheridan, C., Kishimoto, H., Fuchs, R., Mehrotra, S., Bhat-Nakshatri, P., et al. 2006.
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step
necessary for metastasis. Cancer Research 8: R59.
Shipitsin, M., Campbell, L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., et al. 2007.
Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273.
Sleeman, J. and Cremers, N. 2007. New concepts in breast cancer metastasis: tumor initiating
cells and the microenvironment. Clinical & Experimental Metastasis 24: 707-715.
Sneddon, J., Zhen, H., Montgomery, K., et al. 2006. Bone morphogenetic protein antagonist
gremlin1 is widely expressed by cancer-associated stromal cells and can promote tumor cell
proliferation. Proceedings of the National Academy of Science USA 103: 14842-14847.
Sorlie, T., Perou, C., Tibshirani, R., Aas, T., Geisler, S., et al. 2001. Gene expression patterns
of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings
of the National Academy of Science USA 98: 10869-10874.
Steeg, P.S. 2006. Tumor metastasis: mechanistic insights and clinical challenges. Nature
Medicine 12 (8): 895-904.
Stier, S., Ko, Y., Forkert, R., et al. 2005. Osteopontin is a hematopoietic stem cell niche
component that negatively regulates stem cell pool size. Journal of Experimental Medicine
201: 1781-1791.
Stingl, J. and Caldas, C. 2007. Molecular heterogeneity of breast carcinomas and the cancer
stem cell hypothesis. Nature Review Cancer 7: 791-799.
Taichman, R.S., Cooper, C., Keller, E.T., Pienta, K.J., Taichman, N.S., and McCauley, L.K.
2002. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metas-
tasis to bone. Cancer Research 62 (6): 1832-1837.
Tavor, S., Petit, I., Porozov, S., Avigdor, A., Dar, A., et al. 2004. CXCR4 regulates migration
and development of human acute myelogenous leukemia stem cells in transplanted NOD/
SCID mice. Cancer Research 64: 2817-2824.
Turhan, A., Lemoine, F., Debert, C., Bonnet, M., Baillou, C., et al. 1995. Highly purified
primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal
progenitors in acute promyelocytic leukemia. Blood 85: 2154-2161.
van de Vijver, M., He, Y., van't Veer, L., Dai, H., Hart, A., et al. 2002. A gene-expression
signature as a predictor of survival in breast cancer. New England Journal of Medicine 347:
1999-2009.
van't Veer, L., Dai, H., van de Vijver, M., He, Y., Hart, A., et al. 2002. Gene expression
profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
Vescovi, A., Galli, R., and Reynolds, B. 2006. Brain tumour stem cells. Nature Review Cancer
6: 425-436.
Wang, Y., Klijn, J., Zhang, Y., Sieuwerts, A., Look, M., et al. 2005. Gene-expression profiles
to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365:
671-679.
Weigelt, B., Hu, Z., He, X., et al. 2005a. Molecular portraits and 70-gene prognosis signature
are preserved throughout the metastatic process of breast cancer. Cancer Research 65:
9155-9158.
Weigelt, B., Peterse, J.L., and van 't Veer, L.J. 2005b. Breast cancer metastasis: markers and
models. Nature Reviews Cancer 5 (8): 591-602.
Wernig, M., Meissner, A., Foreman, R., et al. 2007. In vitro reprogramming of fibroblasts
into pluripotent ES-cell-like state. Nature 448: 318-324.
